OPPM
Opus Point Partners Management Portfolio holdings
AUM
$46.9M
1-Year Return
4.17%
This Quarter Return
-9.4%
1 Year Return
-4.17%
3 Year Return
+83.22%
5 Year Return
+175.29%
10 Year Return
–
AUM
$46.9M
AUM Growth
-$11.4M
(-20%)
Cap. Flow
-$3.93M
Cap. Flow
% of AUM
-8.38%
Top 10 Holdings %
Top 10 Hldgs %
57.88%
Holding
64
New
2
Increased
18
Reduced
1
Closed
10
Top Buys
| 1 |
Fortress Biotech
FBIO
|
$535K |
| 2 |
United Therapeutics
UTHR
|
$279K |
| 3 |
AMRN
Amarin Corp
AMRN
|
$258K |
| 4 |
Alkermes
ALKS
|
$227K |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$60.5K |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$868K |
| 2 |
Sarepta Therapeutics
SRPT
|
$813K |
| 3 |
BLUE
bluebird bio
BLUE
|
$743K |
| 4 |
Insmed
INSM
|
$690K |
| 5 |
Pacira BioSciences
PCRX
|
$489K |
Sector Composition
| 1 | Healthcare | 64.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Alkermes
ALKS
$4.76B
| $227K | 0.41% |
+11,632
| New | +$227K |
|
52
Ultragenyx Pharmaceutical
RARE
$3.02B
| $217K | 0.39% |
5,064
| – | – |
|
53
FibroGen
FGEN
$47.7M
| $212K | 0.38% |
230
+35
| +18% | +$32.3K |
|
|
SCTL
54
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $126K | 0.23% |
12,659
| – | – |
|
55
Agios Pharmaceuticals
AGIO
$2.01B
| – | – |
-4,806
| Closed | -$240K |
|
56
AnaptysBio
ANAB
$625M
| – | – |
-6,116
| Closed | -$345K |
|
|
BLUE
57
DELISTED
bluebird bio
BLUE
| – | – |
-451
| Closed | -$743K |
|
58
Amicus Therapeutics
FOLD
$2.44B
| – | – |
-36,731
| Closed | -$458K |
|
|
59
Insmed
INSM
$29.9B
| – | – |
-26,936
| Closed | -$690K |
|
60
Madrigal Pharmaceuticals
MDGL
$9.56B
| – | – |
-3,570
| Closed | -$374K |
|
|
61
Pacira BioSciences
PCRX
$1.2B
| – | – |
-11,250
| Closed | -$489K |
|
|
62
Sarepta Therapeutics
SRPT
$1.9B
| – | – |
-5,353
| Closed | -$813K |
|
63
Viking Therapeutics
VKTX
$2.92B
| – | – |
-48,485
| Closed | -$402K |
|
|
IMMU
64
DELISTED
Immunomedics Inc
IMMU
| – | – |
-62,575
| Closed | -$868K |
|